Living with Marfan syndrome III. Quality of life and reproductive planning

Clinical Genetics

Volumn 62, Issue 2, 2002, Pages 110-120

  Peters, Kathryn F ^a,b   Kong, F ^c   Hanslo, M ^d   Biesecker, B B ^b  

^a PENNSYLVANIA STATE UNIVERSITY   (United States)

^b NATIONAL HUMAN GENOME RESEARCH INSTITUTE   (United States)

^c WESTAT   (United States)

^d UNIVERSITY OF CAPE TOWN   (South Africa)

Author keywords

Family; Gender; Genetic counseling; Marfan syndrome; Prenatal diagnosis; Quality of life; Reproduction; Sex drive

Indexed keywords

ADOLESCENT; ADULT; AGE; BACKACHE; CONTROLLED STUDY; CORRELATION FUNCTION; DECISION MAKING; FAMILY PLANNING; FEMALE; GENETIC COUNSELING; HEALTH PRACTITIONER; HEALTH STATUS; HUMAN; LIBIDO; MAJOR CLINICAL STUDY; MALE; MARFAN SYNDROME; MEDICAL ASSESSMENT; MITRAL VALVE PROLAPSE; PATIENT REFERRAL; PREGNANCY COMPLICATION; PRENATAL DIAGNOSIS; PRIORITY JOURNAL; PSYCHOLOGICAL ASPECT; QUALITY OF LIFE; RECURRENCE RISK; RELIGION; REVIEW; RISK ASSESSMENT; SOCIAL PSYCHOLOGY; STRIA; TREATMENT PLANNING; WELLBEING;

ADOLESCENT; ADULT; FAMILY PLANNING SERVICES; FEMALE; HUMANS; MALE; MARFAN SYNDROME; MIDDLE AGED; QUALITY OF LIFE;

EID: 0036705951     PISSN: 00099163     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1399-0004.2002.620203.x     Document Type: Review

References (66)

1. De Paepe A, Devereux RB, Dietz HC, Hennekam RC, Pyeritz RE. Revised diagnostic criteria for the Marfan syndrome. Am J Med Genet 1996: 62: 417-426.
2. Pyeritz R. Disorders of fibrillins and microfibrilogenesis. Marfan syndrome, MASS phenotype, contractural arachnodactyly and related conditions. In: Rimoin, D, Connor, J, Pyeritz, R, eds. Principles and Practice of Medical Genetics, 3rd edn. New York: Churchill Livingstone, 1996.
3. Nienaber CA, Von Kodolitsch Y. Therapeutic management of patients with Marfan syndrome: focus on cardiovascular involvement. Cardiol Rev 1999: 7 (6): 332-341.
4. Dietz HC, Cutting GR, Pyeritz RE et al. Marfan syndrome caused by a recurrent de novo missense mutation in the fibrillin gene. Nature 1991: 352: 337-339.
5. Dietz HC, Pyeritz RE, Hall BD et al. The Marfan syndrome locus: confirmation of assignment to chromosome 15 and identification of tightly linked markers at 15q15-q21.3 Genomics 1991: 9: 355-361.
6. Biery NJ, Eldadah ZA, Moore CS, Stetten G, Spencer F, Dietz HC. Revised genomic organization of FBN1 and significance for regulated gene expression. Genomics 1999: 56 (1): 70-77.
7. Dietz HC, Pyeritz RE. Mutations in the human gene for fibrillin-1 (FBN1) in the Marfan syndrome and related disorders. Hum Mol Genet 1995: 4: 1799-1809.
8. Aoyama T, Francke U, Gasner C, Furthmayr H. Fibrillin abnormalities and prognosis in Marfan syndrome and related disorders. Am J Med Genet 1995: 58: 169-176.
9. Campbell S. The history of the 'Adopt' program. Marfan Matters 1995: August.
10. Peters K, Kong F, Horne R, Francomano F, Biesecker B. Living with Marfan syndrome I. Perceptions of the condition. Clin Genet 2001: 60 (4): 273-282.
11. Sermon K, Lissens W, Messiaen L et al. Preimplantation genetic diagnosis of Marfan syndrome with the use of fluorescent polymerase chain reaction and the automated laser fluorescence DNA sequencer. Fertil Steril 1999: 71 (1): 163-166.
12. Blaszczyk A, Tang YX, Dietz HC et al. Preimplantation genetic diagnosis of human embryos for Marfan's syndrome. J Assist Reprod Genet 1998: 15 (5): 281-284.
13. Grifo JA, Giatras K, Tang YX, Krey LC. Successful outcome with day 4 embryo transfer after preimplantation diagnosis for genetically transmitted diseases. Hum Reprod 1998: 13 (6): 1656-1659.
14. Liu WO, Oefner PJ, Qian C, Odom RS, Francke U. Denaturing HPLC-identified novel FBN1 mutations, polymorphisms, and sequence variants in Marfan syndrome and related connective tissue disorders. Genet Test 1997: 1 (4): 237-242.
15. Nijbroek G, Sood S, McIntosh I et al. Fifteen novel FBN1 mutations causing Marfan syndrome detected by heteroduplex analysis of genomic amplicons. Am J Hum Genet 1995: 57 (1): 8-21.
16. Lind J, Wallenburg HC. The Marfan syndrome and pregnancy: a retrospective study in a Dutch population. Eur J Obstet Gynecol Reprod Biol 2001: 98 (1): 28-35.
17. Paternoster DM, Santarossa C, Vettore N, Dalla Pria S, Grella P. Obstetric complications in Marfan's syndrome pregnancy. Minerva Ginecol 1998: 50 (10): 441-443.
18. Rossiter JP, Repke JT, Morales AJ, Murphy EA, Pyeritz RE. A prospective longitudinal evaluation of pregnancy in the Marfan syndrome. Am J Obstet Gynecol 1995: 173 (5): 1599-1606.
19. Lipscomb KJ, Smith JC, Clarke B, Donnai P, Harris R. Outcome of pregnancy in women with Marfan's syndrome. Br J Obstet Gynaecol 1997: 104 (2): 201-206.
20. Elkayam U, Ostrzega E, Shotan A, Mehra A. Cardiovascular problems in pregnant women with the Marfan syndrome. Ann Intern Med 1995: 123 (2): 117-122.
21. Pyeritz RE. Maternal and fetal complications of pregnancy in the Marfan syndrome. Am J Med 1981: 71 (5): 784-790.
22. Shabetai R. Cardiac diseases. In: Creasy R, Resnick R, eds. Maternal-Fetal Medicine: Principles and Practice, 3rd edn. Philadelphia: W.B. Saunders, 1994: 768-791.
23. George L, Bearon L. Quality of Life in Older Persons. New York: Human Sciences Press, 1980.
24. Ferrans C. Conceptualizations of quality of life in cardiovascular research. Prog Cardiovasc Nurs 1992: 7 (1): 2-6.
25. Ferrans C, Powers M. Psychometric assessment of the Quality of Life Index. Res Nurs Health 1992: 15: 29-38.
26. Schneider MB, Davis JG, Boxer RA, Fisher M, Friedman SB. Marfan syndrome in adolescents and young adults: psychosocial. functioning and knowledge. J Dev Behav Pediatr 1990: 11 (3): 122-127.
27. Van Tongerloo A, De Paepe A. Psychosocial adaptation in adolescents and young adults with Marfan syndrome: an exploratory study. J Med Genet 1998: 35: 405-409.
28. Minnich A. Attitudes, feelings, and perceptions of women with Marfan syndrome toward childbearing. Masters, California State University, Long Beach, CA, 1997.
29. Peters K, Horne R, Kong F, Francomano C, Biesecker B. Living with Marfan syndrome II. Medication adherence and physical activity modification. Clin Genet 2001: 60 (4): 283-292.
30. Weinman J, Petrie KJ, Moss-Morris R, Horne R. The Illness Perception Questionnaire a new method for assessing the cognitive representation of illness. Psychol Health 1996: 11: 431-445.
31. Ferrans C, Powers M. Quality of Life Index: development and psychometric properties. Adv Nurs Sci 1985: 8: 15-24.
32. Papadantonaki A, Stotts NA, Paul SM. Comparison of quality of life before and after coronary artery bypass surgery and percutaneous transluminal angioplasty. Heart Lung 1994: 23 (1): 45-52.
33. Roseberg M. Society and the Adolescent Self-image, revised edn. Middletown, CT: Wesleyan University Press, 1989.
34. Moos R, Moos B. Family Environment Scale Manual. Development, Applications, and Research, 3rd edn. Palo Alto: Consulting Psychologists Press Inc, 1994.
35. Spanier G. Measuring dyadic adjustment: new scales for assessing the quality of marriage and similar dyads. J Marr Fam 1976: 38: 15-28.
36. Shiloh S. Decision-making in the context of genetic risk. In: Marteau T, Richards M, eds. The Troubled Helix. Social and Psychological Implications of the New Human Genetics. Cambridge: Cambridge University Press, 1996: 82-103.
37. Gollust S, Gooding H, Thompson R, Biesecker B. Living with achondroplasia in an average-sized world. Am J Med Genet (in press).
38. Lippman-Hand A, Fraser FC. Genetic counseling: parents' responses to uncertainty. Birth Defects Orig Artic Ser 1979: 15 (5C): 325-339.
39. Beeson D, Golbus MS. Decision making: whether or not to have prenatal diagnosis and abortion for X-linked conditions. Am J Med Genet 1985: 20 (1): 107-114.
40. Rapp R. Testing Women, Testing the Fetus: The Social Impact of Amniocentesis in America. New York: Routledge, 2000.
41. Markel DS, Young AB, Penney JB. At-risk persons' attitudes toward presymptomatic and prenatal testing of Huntington disease in Michigan. Am J Med Genet 1987: 26 (2): 295-305.
42. Wertz DC, Janes SR, Rosenfield JM, Erbe RW. Attitudes toward the prenatal diagnosis of cystic fibrosis: factors in decision making among affected families. Am J Hum Genet 1992: 50 (5): 1077-1085.
43. Middleton A, Hewison J, Mueller R. Prenatal diagnosis for inherited deafness - what is the potential demand? J Genet Counsel 2001: 10 (2): 121-131.
44. Mansfield C, Hopfer S, Marteau TM. Termination rates after prenatal diagnosis of Down syndrome, spina bifida, anencephaly, and Turner and Klinefelter syndrome: a systematic literature review. Prenatal Diagnosis 1999: 19 (9): 808-812.
45. Bell M, Stonemann Z. Reactions to prenatal testing: reflections of religiosity and attitudes toward abortion and people with disabilities. Am J Mental Retard 2000: 105 (1): 1-13.
46. Meryash DL, Abuelo D. Counseling needs and attitudes toward prenatal diagnosis and abortion in fragile-X families. Clin Genet 1988: 33 (5): 349-355.
47. Saleem. R, Gofin R, Ben-Neriah Z, Boneh A. Variables influencing parental perception of inherited metabolic diseases before and after genetic counselling. J Inherit Metab Dis 1998: 21 (7): 769-780.
48. Weil J. Mothers' postcounseling beliefs about the causes of their children's genetic disorders. Am J Hum Genet 1991: 48 (1): 145-153.
49. Furr LA, Seger RE. Psychosocial predictors of interest in prenatal genetic screening. Psychol Rep 1998: 82 (1): 235-244.
50. Basson R, Berman J, Burnett A et al. Report of the international consensus development conference on female sexual dysfunction: definitions and classifications. J Urol 2000: 163 (3): 888-893.
51. NIH Consensus Conference. Impotence. NIH Consensus Development Panel on Impotence. J Am Med Assoc 1993: 270 (1): 83-90.
52. Rosen RC. Prevalence and risk factors of sexual dysfunction in men and women. Curr Psychiatry Rep 2000: 2 (3): 189-195.
53. Biesecker BB, Peters KF. Process studies in genetic counseling: peering into the black box. Am J Med Genet 2001: 106 (3): 191-198.
54. Fraser FC. Genetic counseling. Am J Hum Genet 1974: 26 (5): 636-661.
55. Fine BA, Baker DL, Fiddler MB, Consortium ACD. Practice-based competencies for accreditation of and training in graduate programs in genetic counseling. J Genet Counsel 1996: 5 (3): 113-122.
56. Peters-Brown T, Fry-Mehltretter L. Genetic counseling for pregnant adolescents. J Genet Counsel 1996: 5 (4): 155-168.
57. Frets PG, Niermeijer MF. Reproductive planning after genetic counselling: a perspective from the last decade. Clin Genet 1990: 38 (4): 295-306.
58. Frets PG, Duivenvoorden HJ, Verhage F, Ketzer E, Niermeijer MF. Model identifying the reproductive decision after genetic counseling. Am J Med Genet 1990: 35 (4): 503-509.
59. Frets PG, Duivenvoorden HJ, Verhage F, Niermeijer MF, van de Berge SM, Galjaard H. Factors influencing the reproductive decision after genetic counseling. Am J Med Genet 1990: 35 (4): 496-502.
60. Lippman-Hand A, Fraser FC. Genetic counseling - the postcounseling period. II. Making reproductive choices. Am J Med Genet 1979: 4 (1): 73-87.
61. Kessler S. Psychological aspects of genetic counseling VI. A critical review of the literature dealing with education and reproduction. Am J Med Genet 1989: 34: 340-353.
62. Weil J. Psychosocial Genetic Counseling. New York, NY: Oxford University Press, 2000.
63. Fanos JH. Developmental tasks of childhood and adolescence: implications for genetic testing. Am J Med Genet 1997: 71 (1): 22-28.
64. Hayden MR. Predictive testing for Huntington's disease: the calm after the storm. Lancet 2000: 356 (9246): 1944-1945.
65. Aro A, Hakonen A, Hietala M et al. Acceptance of genetic testing in a general population: age, education, and gender differences. Patient Ed Counsel 1997: 32: 41-49.
66. Harter S. Is self-esteem only skin deep? The inextricable link between physical appearance and self-esteem. Reclaim Children Youth 2002: 9 (3): 133-138.